# System consolidation: how scale becomes leverage
In 2013, two hospital systems in Northern California, Sutter Health, put their combined weight behind a single message to insurers: contract with all our hospitals, or none. That "all-or-nothing" bargaining eventually drew a lawsuit from California's Attorney General and a $575 million settlement in 2019. The lesson every hospital executive took away was not "don't consolidate." It was "consolidate carefully, because scale is the single most reliable way to raise prices."
This lesson traces exactly how that works: how combining hospitals flips the negotiation against insurers, why commercial rates rise 10 to 20 percent, and why regulators keep arriving late.
To understand the power shift, you need the two main players.
Providers: hospitals and hospital systems. A "system" is a group of hospitals under common ownership (for example HCA Healthcare, CommonSpirit Health, or Advocate Health in the US).
Payers: health insurers who pay providers on behalf of patients. In the US, the big commercial payers are UnitedHealthcare, Elevance (formerly Anthem), Aetna (CVS Health), and Cigna. "Commercial" means employer and individual insurance, as opposed to government programs (Medicare for seniors, Medicaid for low-income patients).
The key fact: government rates are set by regulation, commercial rates are negotiated. Medicare and Medicaid pay fixed, formula-driven prices that hospitals cannot bargain up. So the entire fight over pricing power happens in the commercial contract. That is where consolidation pays off.
If the hospital walks away, Aetna's network still has three other hospitals in the metro area. The employer barely notices. The hospital, meanwhile, loses a big chunk of insured patients overnight. The insurer holds the leverage.
Now the hospital's negotiating range is narrow. It cannot push rates far above cost, because it is replaceable.
Merge that hospital with the other three in the metro. Now there is one system controlling most inpatient beds in the region.
The math for the insurer inverts. If the system walks, Aetna cannot build a credible network. Employers will not buy insurance that excludes the region's dominant hospitals, especially the ones with the only trauma center, NICU (neonatal intensive care unit), or transplant program. The insurer becomes the replaceable party.
This is called a "must-have" system. Once a hospital group is must-have, it can demand higher rates, and the insurer largely has to pay, because passing on the deal means losing employer clients.
Consolidation unlocks a specific tactic: bundling contracts across all facilities. The Sutter case showed the playbook. A system with one prestige academic hospital and several ordinary community hospitals says: to get the prestige hospital in your network, you must take all of them, at rates we set.
The insurer needs the crown-jewel hospital. To get it, they overpay for the rest. That is how scale converts one strong asset into system-wide pricing power.
The often-cited estimate is that mergers raise prices by roughly 10 to 20 percent, and higher (sometimes 40 percent plus) when the merging hospitals were close local competitors. These figures come from health economics research; a good, readable summary of the evidence is the Nicholas Bloom and Zack Cooper work via the Health Care Pricing Project. Treat these as academic estimates, not guarantees.
Here is a simplified worked example. Numbers are illustrative, not real contract data.
That last point is what regulators worry about. The extra $27 million is not from better outcomes or lower costs. It is pure negotiating leverage, and it flows to premiums that employers and workers ultimately pay.
Follow the money down the chain.
1. System raises commercial rates.
2. Insurer pays more, then raises premiums to employers.
3. Employers pass costs to workers via higher premium contributions, higher deductibles, or lower wage growth.
The patient rarely sees the hospital price directly. That opacity is why the leverage is so durable: the people paying (workers) are far from the people negotiating (system and insurer).
Merger review in the US runs through two agencies: the Federal Trade Commission (FTC) and the Department of Justice (DOJ) Antitrust Division. They review deals under the Clayton Act (the antitrust law that bars mergers that "substantially lessen competition") using the Hart-Scott-Rodino (HSR) Act, which requires companies to notify regulators before large mergers close.
Three structural reasons they struggle:
Cross-market mergers slip through. Traditional review asks: do these two hospitals compete in the same local market? If System X buys hospitals in different cities, there is no obvious head-to-head overlap, yet the combined system still gains bundling leverage with statewide insurers. Regulators have only recently started challenging these.
Nonprofit status confuses the picture. Many large systems are nonprofit. Regulators and courts historically assumed nonprofits would not exploit market power. Evidence shows nonprofit systems raise prices too.
"Physician roll-ups" fly under the radar. Systems buy up independent doctor practices one at a time. Each deal is small enough to fall below the HSR reporting threshold (around $126.4 million for 2025, adjusted annually; confirm the current figure at the FTC's HSR thresholds page). Dozens of small deals add up to regional dominance no single filing ever flagged.
In 2023 the FTC and DOJ issued updated Merger Guidelines explicitly addressing serial acquisitions and cross-market effects, a sign the enforcers are trying to catch up. Whether courts follow is still being tested.
In much of Europe, the payer is the state. In England, the NHS (National Health Service) both funds and largely provides care, so there is no commercial rate negotiation of the US kind. In Germany and the Netherlands, insurers negotiate with hospitals, but within tighter regulated price frameworks. The result: hospital consolidation happens in Europe too, but the "raise commercial rates 15 percent" lever is far weaker because the state caps or steers prices. The pricing power story in this lesson is mostly a US phenomenon.
Vérification des acquis
1. Why does hospital consolidation primarily affect commercial rates rather than government program rates?
2. What is the core mechanism by which combining hospitals into a system increases negotiating leverage over insurers?
3. An 'all-or-nothing' bargaining demand works by exploiting which underlying dynamic?
4. Select ALL correct answers about why a standalone community hospital has weak bargaining leverage against a large payer.
Sélectionnez toutes les réponses correctes.
5. Select ALL correct answers describing lessons hospital executives drew from consolidation cases like the Sutter Health settlement.
Sélectionnez toutes les réponses correctes.
Payers are not passive. They merge and integrate to rebuild their own leverage.
The clearest move is vertical integration: insurers buying providers directly. UnitedHealth's Optum unit now employs or is affiliated with tens of thousands of physicians, making UnitedHealth one of the largest employers of doctors in the US. CVS Health owns Aetna and the provider group Oak Street Health.
When an insurer owns providers, it can steer patients to its own lower-cost sites and weaken a hospital system's must-have status. The power balance becomes an arms race: systems consolidate to raise rates, insurers integrate to resist and to capture margin themselves. The patient and employer sit in the middle, funding both sides.
When you assess a regional hospital market, ask four questions:
1. Is any system "must-have"? Does it hold the only trauma center, the dominant brand, or most beds?
2. Can insurers build a network without it? If no, the system has pricing power.
3. Is consolidation happening below the radar? Watch physician roll-ups and cross-market deals.
4. How integrated are the payers? An Optum-style insurer changes the fight entirely.